“In my company, CME is now considered too risky. We're pulling back,” said a participant at the Pharmaceutical Alliance for CME breakout session at the American Medical Association's conference on CME Provider/Industry Collaboration, held in September in Baltimore.
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments
